A convenient, effective, and low-cost method was developed for the determination of 38 pharmaceuticals and personal care products (PPCPs), including 19 antibiotics in surface water samples by lyophilization combined with liquid chromatography-tandem quadrupole mass spectrometry (LC-MS/MS). The components of the extraction solvent, the volume of the water sample, and the volume of extraction solvent were successively optimized. The analytes in 80 mL water samples were concentrated by lyophilization, eluted effectively by the solvent of 2 mL acetonitrile, 2 mL acetone, and 2 mL ultrapure water. The method detection limits ranged from 0.02 ng L-1 (caffeine) to 0.17 μg L-1 (glibenclamide). The recoveries of 30 analytes ranged from 40.0% (sulfaguanidine) to 124.4% (flumequine). The relative standard deviations of all analytes were below 21% except ciprofloxacin (29%). The performance of the optimized method was comparable to the solid phase extraction and ultrasonic extraction method with much less consumption of labor, organic solvent, and consumables. The developed method was successfully applied to surface river water, reservoir water, and effluent of the wastewater treatment plant.

Download full-text PDF

Source
http://dx.doi.org/10.1039/d0ay02022bDOI Listing

Publication Analysis

Top Keywords

determination pharmaceuticals
8
pharmaceuticals personal
8
personal care
8
care products
8
lyophilization combined
8
combined liquid
8
liquid chromatography-tandem
8
mass spectrometry
8
water samples
8
extraction solvent
8

Similar Publications

Introduction: China implemented a dynamic zero-COVID strategy to curb viral transmission in response to the coronavirus disease 2019 (COVID-19) pandemic. This strategy was designed to inhibit mutation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible for COVID-19. This study explores the dynamics of viral evolution under stringent non-pharmaceutical interventions (NPIs) through real-world observations.

View Article and Find Full Text PDF

BACKGROUND Periodontal disease and rheumatoid arthritis (RA) are closely related, and periodontal therapy can potentially improve RA activity. However, it is not clear in which RA patient populations are more effective periodontal therapy for RA treatment. This study aimed to evaluate the effects of treatment for periodontal disease in 30 patients with rheumatoid arthritis and the titers of antibodies to Porphyromonas gingivalis (P.

View Article and Find Full Text PDF

One hallmark of cancer is the upregulation and dependency on glucose metabolism to fuel macromolecule biosynthesis and rapid proliferation. Despite significant pre-clinical effort to exploit this pathway, additional mechanistic insights are necessary to prioritize the diversity of metabolic adaptations upon acute loss of glucose metabolism. Here, we investigated a potent small molecule inhibitor to Class I glucose transporters, KL-11743, using glycolytic leukemia cell lines and patient-based model systems.

View Article and Find Full Text PDF

Background: SHEN26 (ATV014) is an oral RNA-dependent RNA polymerase (RdRp) inhibitor with potential anti-SARS-CoV-2 activity. Safety, tolerability, and pharmacokinetic characteristics were verified in a Phase I study. This phase II study aimed to verify the efficacy and safety of SHEN26 in COVID-19 patients.

View Article and Find Full Text PDF

Background: Bear bile powder (BBP), a unique animal-derived medicine with anti-inflammatory and antioxidant effects, is used in Shexiang Tongxin dropping pills (STDP), which is applied to treat cardiovascular diseases, including acute myocardial infarction (AMI). The efficacy and compatibility mechanisms of action of BBP in STDP against cardiovascular diseases remain unclear. This study aimed to investigate the compatibility effects of BBP in STDP in rats with AMI.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!